SHIP2-SRC-β-catenin signaling axis sustains thymidylate synthase expression and promotes fluoropyrimidine resistance.
Abdulrahman El Sayed, Abdelhalim Azzi
This study identifies SHIP2 as a regulator of TYMS expression and fluoropyrimidine resistance in breast cancer by promoting β-catenin nuclear accumulation and SRC activity.
bioRxiv · Jun 9, 2026 · PreprintCancer Biology